Distinct actions of etomidate and propofol at beta3-containing gamma-aminobutyric acid type A receptors.
Neuropharmacology. 2009 Sep; 57(4):446-55
Drexler B, Jurd R, Rudolph U, Antkowiak B. Neuropharmacology. 2009 Sep; 57(4):446-55
Although propofol and etomidate similarly bind to and modulate beta subunit-containing gamma-aminobutyric acid (GABA)A receptors, they have been shown to produce distinct actions on the central nervous system (CNS) (e.g. electroencephalogram [EEG] activity and somatosensory evoked potentials [SSEPs]). This interesting study suggests...
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.